Cell‐Free Fetal DNA Screening for Chromosomal Anomalies: Green‐Top Guideline No. 77

Cell-Free Fetal DNA Testing for Chromosomal Conditions (T21, T18, T13)• Cell-free fetal DNA (cffDNA) testing can be safely and feasibly offered to women either as a first line screening test in unselected populations, or within a contingent model for the accurate identification of fetuses with trisomies 21, 18 and 13 (T21, T18 and T13).[Grade A]• In the setting of raised nuchal translucency (3.5mm or greater) or the finding of a fetal anomaly, women should be referred to a fetal medicine unit and, where indicated, offered invasive diagnostic testing.In a setting where invasive testing has been declined, cffDNA testing may be offered.[Grade A]• For women who have a higher chance for T21, T18 or T13 due to a previous affected pregnancy, cffDNA testing should be offered as a first line screening test.[GPP]• Pregnant women must be informed that cffDNA testing is a form of prenatal screening as opposed to a diagnostic test.[Grade A]• In test failure due to low cffDNA fetal fraction, the presence of T18 and T13 should be considered.[Grade B]• When cffDNA fails to yield a result, a detailed review of the woman's initial a priori chance and indications for cffDNA testing should be undertaken.[GPP] • Women who want to avoid a diagnostic test and would wish to continue a pregnancy with T21, T18 or T13, may still value the information a cffDNA test can give them.This is a valid choice and must be respected.[GPP] Expanding the Use of cffDNA Testing Beyond the Detection of T21, T18 and T13• cffDNA testing for detection of copy number variants is not currently recommended.[Grade B]• cffDNA testing for rare autosomal trisomies (RATs) is not currently recommended.[Grade B] cffDNA Testing in the Setting of Multiple Pregnancy• cffDNA testing may be offered to women with a twin pregnancy.[Grade A]• There is a higher chance of a false positive result with a vanishing twin, and therefore cffDNA testing in the presence of a vanishing twin is not recommended.[Grade C]• cffDNA testing cannot currently be recommended for aneuploidy screening in triplet or higher order multiple pregnancy.[Grade D]

Authors

Institutions

Publication Details

Journal
BJOG An International Journal of Obstetrics & Gynaecology
Published
2026-11-17
DOI
https://doi.org/10.1111/1471-0528.70337
Primary Topic
Prenatal Screening and Diagnostics
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Cell‐Free Fetal DNA Screening for Chromosomal Anomalies: Green‐Top Guideline No. 77

Surabhi Nanda, Fionnuala Mone, Aris T. Papageorghiou, Kypros H. Nicolaides et al.
1 links
BJOG An International Journal of Obstetrics & Gynaecology
Prenatal Screening and Diagnostics
article

Cell‐Free Fetal DNA Screening for Chromosomal Anomalies: Green‐Top Guideline No. 77

Surabhi Nanda, Fionnuala Mone, Aris T. Papageorghiou, Kypros H. Nicolaides, Mark David Kilby, Jane Fisher, Pranav Pandya, Jehan Karim
article en

Abstract

Cell-Free Fetal DNA Testing for Chromosomal Conditions (T21, T18, T13)• Cell-free fetal DNA (cffDNA) testing can be safely and feasibly offered to women either as a first line screening test in unselected populations, or within a contingent model for the accurate identification of fetuses with trisomies 21, 18 and 13 (T21, T18 and T13).[Grade A]• In the setting of raised nuchal translucency (3.5mm or greater) or the finding of a fetal anomaly, women should be referred to a fetal medicine unit and, where indicated, offered invasive diagnostic testing.In a setting where invasive testing has been declined, cffDNA testing may be offered.[Grade A]• For women who have a higher chance for T21, T18 or T13 due to a previous affected pregnancy, cffDNA testing should be offered as a first line screening test.[GPP]• Pregnant women must be informed that cffDNA testing is a form of prenatal screening as opposed to a diagnostic test.[Grade A]• In test failure due to low cffDNA fetal fraction, the presence of T18 and T13 should be considered.[Grade B]• When cffDNA fails to yield a result, a detailed review of the woman's initial a priori chance and indications for cffDNA testing should be undertaken.[GPP] • Women who want to avoid a diagnostic test and would wish to continue a pregnancy with T21, T18 or T13, may still value the information a cffDNA test can give them.This is a valid choice and must be respected.[GPP] Expanding the Use of cffDNA Testing Beyond the Detection of T21, T18 and T13• cffDNA testing for detection of copy number variants is not currently recommended.[Grade B]• cffDNA testing for rare autosomal trisomies (RATs) is not currently recommended.[Grade B] cffDNA Testing in the Setting of Multiple Pregnancy• cffDNA testing may be offered to women with a twin pregnancy.[Grade A]• There is a higher chance of a false positive result with a vanishing twin, and therefore cffDNA testing in the presence of a vanishing twin is not recommended.[Grade C]• cffDNA testing cannot currently be recommended for aneuploidy screening in triplet or higher order multiple pregnancy.[Grade D]

BJOG An International Journal of Obstetrics & Gynaecology
Royal College of Obstetricians and Gynaecologists (GB)
Public Health Wales, University of Oxford, Kementerian Pendidikan Nasional
Good health and well-being
Prenatal Screening and Diagnostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon